Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer’s disease progression

We conducted a randomized placebo-controlled double-blind 24-week trial using Melissa officinalis (M. officinalis) extract richly containing rosmarinic acid (RA) on patients with mild dementia due to Alzheimer’s disease (AD) with the aim to examine the safety and tolerability (primary endpoint) of R...

Descripción completa

Detalles Bibliográficos
Autores principales: Noguchi-Shinohara, Moeko, Ono, Kenjiro, Hamaguchi, Tsuyoshi, Nagai, Toshitada, Kobayashi, Shoko, Komatsu, Junji, Samuraki-Yokohama, Miharu, Iwasa, Kazuo, Yokoyama, Kunihiko, Nakamura, Hiroyuki, Yamada, Masahito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596544/
https://www.ncbi.nlm.nih.gov/pubmed/33122694
http://dx.doi.org/10.1038/s41598-020-73729-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596544/
https://www.ncbi.nlm.nih.gov/pubmed/33122694
http://dx.doi.org/10.1038/s41598-020-73729-2

Ejemplares similares